Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2002-8-12
pubmed:abstractText
Myocardial viability can be defined as functional improvement of dysfunctional myocardium after revascularization. The purpose of this study was to define the optimal criteria for definition of regional functional improvement after coronary artery bypass graft (CABG) surgery on quantitative gated single-photon emission tomography (SPET). Thirty-two patients (26 men, 6 women; age 56 +/- 13 years) with coronary artery disease (three-vessel disease, 17; two-vessel disease, 15; previous history of myocardial infarction, 9) and severe left ventricular dysfunction (LVEF < or = 35%) underwent CABG. Rest thallium-201/dipyridamole stress technetium-99m methoxyisobutylisonitrile gated myocardial SPET was performed before and 3 months after CABG. Global LV functional improvement was defined as either an improvement in LVEF of 10% ( n = 15) or an improvement in LVEF of 5% combined with a decrease in end-systolic volume of 10 ml ( n = 2) after CABG on quantitative gated SPET. Postoperative regional wall thickening improvement (DeltaRWT), regional wall motion improvement (DeltaRWM) and regional resting (DeltaRP) and stress perfusion improvement (DeltaRstrP) were used to determine global functional improvement by ROC curve analysis, and the optimal criteria for definition of viable regional dysfunctional myocardium were defined on the ROC curves. Correlations were verified by determining the number of improved myocardial regions and LVEF improvement. LVEF was improved from 25% +/- 6% to 34% +/- 11% after CABG. A total of 229 segments were dysfunctional (wall motion < or = 2 mm, thickening < or = 20%) before CABG. On ROC curve analysis using global functional improvement as an indicator of viability, the areas under the ROC curves (AUCs) of DeltaRWT and DeltaRWM were 0.717 and 0.620, respectively. The AUC of DeltaRWT was significantly larger than that of DeltaRWM ( P = 0.009) and the optimal cut-off value of DeltaRWT was 15%. The AUCs of DeltaRP and DeltaRstrP were not significant. The correlation coefficients between summed DeltaRWT and DeltaRWM and LVEF improvement were 0.591 and 0.472, respectively. The number of segments with a DeltaRWT of more than 15% correlated with LVEF improvement (rho = 0.533 by Spearman rank correlation). Regional wall thickening improvement showed the best correlation with global LV functional improvement after CABG. The most reliable regional criterion of myocardial viability was improvement in regional wall thickening by > or = 15% on quantitative gated SPET.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1619-7070
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1078-82
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12173023-Cardiac Volume, pubmed-meshheading:12173023-Coronary Artery Bypass, pubmed-meshheading:12173023-Coronary Artery Disease, pubmed-meshheading:12173023-Exercise Test, pubmed-meshheading:12173023-Female, pubmed-meshheading:12173023-Gated Blood-Pool Imaging, pubmed-meshheading:12173023-Heart Ventricles, pubmed-meshheading:12173023-Humans, pubmed-meshheading:12173023-Male, pubmed-meshheading:12173023-Middle Aged, pubmed-meshheading:12173023-Myocardial Ischemia, pubmed-meshheading:12173023-Postoperative Care, pubmed-meshheading:12173023-Preoperative Care, pubmed-meshheading:12173023-ROC Curve, pubmed-meshheading:12173023-Sensitivity and Specificity, pubmed-meshheading:12173023-Stroke Volume, pubmed-meshheading:12173023-Tomography, Emission-Computed, Single-Photon, pubmed-meshheading:12173023-Treatment Outcome, pubmed-meshheading:12173023-Ventricular Dysfunction, Left
pubmed:year
2002
pubmed:articleTitle
Criteria for definition of regional functional improvement on quantitative post-stress gated myocardial SPET after bypass surgery in patients with ischaemic cardiomyopathy.
pubmed:affiliation
Department of Nuclear Medicine, Seoul National University College of Medicine, 110-744, Chongno-gu, Yongun-dong 28, Seoul, Korea. dsl@plaza.snu.ac.kr
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study